Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma.
Yuen S, Phillips TJ, Bannerji R, Marlton P, Gritti G, Seymour JF, Johnston A, Arthur C, Dodero A, Sharma S, Hirata J, Musick L, Flowers CR.
Yuen S, et al. Among authors: johnston a.
Am J Hematol. 2024 Jul;99(7):1281-1289. doi: 10.1002/ajh.27341. Epub 2024 May 3.
Am J Hematol. 2024.
PMID: 38700035
Clinical Trial.